NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Accuryn Medical

Accuryn Medical

Private
Hayward, CaliforniaHealthcare & Life Scienceshttps://accuryn.com/

Last Round

Private Equity

Feb 8, 2024

Est. Valuation

$122.54M

Total Funding Raised

$103.25M

Company Overview

Accuryn Medical is a healthcare technology company that develops a predictive health monitoring system for critical care settings, utilizing smart sensors and artificial intelligence to automate urine output, intra-abdominal pressure, and core body temperature measurements.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Healthcare Analytics, Medical AI

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

acute kidney injuryAKIurine output monitoringintra-abdominal pressurecritical care monitoringsmart foley catheterclinical decision supportpredictive analyticsfluid managementmedical deviceicu technologybedside monitoringpatient monitoring systemmedtechdigital health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Accuryn Medical Comparables

Compare Accuryn Medical with similar companies based on industry and business-model similarity.

Accuryn Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CardioRenal Systems
87%
Fize Medical
85%
RenalSense Ltd.
83%

Accuryn Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquityFeb 8, 2024
Series DApr 7, 2023
Series C ExtensionOct 29, 2019
Series C ExtensionJul 12, 2019
Series CJul 9, 2018
Series B
Aug 7, 2017

Key People

Founding team and executive leadership

Rich Keenan

Chief Product Officer

Executive Team

Accuryn Medical Investors

Notable investors and investment history

Accuryn Medical investors
InvestorRounds
Scientific Health DevelopmentSeed, Series D
NIH RADxGrant
TheraNovaSeed
U.S. Department of WarGrant
GT Healthcare Capital PartnersSeries C
Sonder CapitalSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 21, 2025

    Todd Dunn appointed as the new Chief Executive Officer.

  • Feb 8, 2024

    Raised $10M in a Private Equity round.

Accuryn Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Accuryn Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Accuryn Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersHayward, California
Employee Range38
Year Founded2011
Last FundingFeb 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.